Let’s accelerate RNA medicines together.
We are open to exploring partnerships that accelerate the development and reach of our RNA therapeutics platform.
Where our platform is already at work
ValamAi’s mRNA platform is amenable to a broad range of nucleotide therapy approaches.
Urology
VMB-100 in stress urinary incontinence.
Orthopedics & spine
VMB-100 in disc herniation.
Dermatology
VAI-002 topical RNA cream for androgenetic alopecia.
Oncology
VAI-003 combining mRNA and siRNA in one molecule.
Ways to work with us
We welcome conversations with pharmaceutical and biotechnology companies.
Co-development
Advance programs jointly, combining our platform with your development and commercial strengths.
Licensing
License ValamAi assets or technology for specific indications or territories.
Platform collaborations
Apply our mRNA platform to your targets of interest.
Discuss a partnership
Get in touch via our contact page and a member of our business development team will follow up.